Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72–3. Jurgeit A, McDowell R, Moese S, Meldrum E, Schwendener R, Greber UF. Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects. PLoS Pathog. 2012;8(10):e1002976. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–71. Chu C, Cheng V, Hung I, Wong M, Chan K, Chan K, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59(3):252–6.

GEORGALA, Sofia; KATOULIS, Alexander C.; BEFON, Angeliki. Inosiplex for treatment of alopecia areata: a randomized placebo-controlled study. Acta Dermato-Venereologica. 2006, roč. 86, čís. 5, s. 422–424. PMID 16955187. Dostupné online [cit. 2021-04-02]. ISSN 0001-5555. DOI 10.2340/00015555-0138. PMID 16955187.For more information about any other possible risks associated with this medicine, please read the information provided with the medicine or consult your doctor or pharmacist. Ca toate medicamentele, acest medicament poate determina reactii adverse, cu toate ca nu apar la toate persoanele. Odporúčaná denná dávka je 50 mg/kg (1 tableta na 10 kg), zvyčajne 3 g/deň až do maximálnej dávky 4 g/deň, podávaná perorálne v 3-4 rovnakých dávkach počas dňa.

Chen W, Mook RA, Premont RT, Wang J. Niclosamide: beyond an antihelminthic drug. Cell Signal. 2018;41:89–96. tratament adjuvant in infectii cutaneo-mucoase, vulvo-vaginale (subclinice) sau endocervicale provocate de Papilomavirus uman (HPV); PMCID: PMC2545279. Dostupné online [cit. 2021-04-02]. ISSN 0267-0623. DOI 10.1136/bmj.296.6622.646-b. PMID 2450620. Spuneti medicului dumneavoastra sau farmacistului daca luati, ati luat recent sau s-ar putea sa luati orice alte medicamente.Lopinavir is a protease inhibitor used commonly for the treatment of HIV 1 infection. Ritonavir is used for boosting the lopinavir levels as a combination in sub-therapeutic doses for its inhibitory action on CYP3A4. In HIV, LPV inhibits the protease enzyme (aspartic protease family), thereby preventing the cleavage of Gag-Pol protein precursors. This results in the formation of immature and non-infectious virions. It is postulated that LPV has similar action on SARS-CoV-1 by inhibiting the chymotrypsin-like protease.